Inhibition of proteasome deubiquitinating activity as a new cancer therapy

Cancer cell sensitivity to bortezomib is associated with survivin and p53 status but not cancer cell types

(2010) Xiang Linf et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Enhancement of proteasome activity by a small-molecule inhibitor of USP14

(2010) Byung-Hoon Lee et al.   NATURE

Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating Enzymes

(2009) Francisca E. Reyes-Turcu et al.   Annual Review of Biochemistry

The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies

(2008) L. Paoluzzi et al.   BLOOD

Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin-proteasome system

(2008) Maria Berndtsson et al.   INTERNATIONAL JOURNAL OF CANCER

Relative Structural and Functional Roles of Multiple Deubiquitylating Proteins Associated with Mammalian 26S Proteasome

(2007) Elena Koulich et al.   MOLECULAR BIOLOGY OF THE CELL